A study on Onglyza diabetes medication and its side effects was conducted and published on the New England Journal of Medicine. The study is known as SAVOR and it discovered that patients who take Onlyza were 27% likelier to be hospitalized for deadly heart failure. Although Onglyza is FDA-approved for controlling blood sugar levels, it has dangerous side effects. A solid onglyza heart failure connection was established by the study, resulting in a class action lawsuit that was settled by the makers of the drug. You should take other drugs on top of Onlyza in order to reduce your risk of heart failure. The makers didn’t warn patients enough about this side effect though. The study took place for two years and involved 16,000 patients taking a placebo or Onglyza.
Onglyza and Its Side Effects
• The (undisclosed by label) side effects of Onglyza that AstraZeneca failed to reveal by packaging, medicine label, and by instruction booklet includes increased risk of heart attack, heart disease, and heart failure. It can also make it difficult for you to breathe, cause pancreatitus, and result in headache. No wonder AstraZeneca has been sued left and right for their negligence.
• You can also suffer from urinary tract infection, swelling or fluid retention, low blood sugar or hypoglycemia, and the like when taking Onglyza on top of the 27% increase in heart failure risk. What’s worse is that Onglyza gets 1.7 million prescriptions annually, making it a highly popular anti-diabetes drug with a highly deadly side effect that affects potentially thousands of patients. It can be prescribed with a combination of other diabetes medications.
• But at best it should be prescribed with anti-cardiovascular-disease drugs as well to mitigate the heart failure side effect. As far as the Onglyza lawsuit is concerned, there have been victims of Onglyza speaking out and filing their own cases to get death compensation or hospitalization reimbursements from the lack of warnings on the labels of Onglyza bottles and packaging. That’s the bottom line about Onglyza.